[
  {
    "date": "2023-10-31",
    "symbol": "CMND",
    "period": "FY",
    "cashandcashequivalents": 5427739,
    "othercurrentreceivables": 104320,
    "shortterminvestmentsclassifiedascashequivalents": 86112,
    "currentprepaidexpenses": 40403,
    "tradeandothercurrentreceivablesduefromrelatedparties": 136002,
    "currentassets": 5794576,
    "propertyplantandequipment": 1727,
    "intangibleassetsotherthangoodwill": 119310,
    "currentrestrictedcashandcashequivalents": 37675,
    "noncurrentassets": 158712,
    "assets": 5953288,
    "currentaccruedexpensesandothercurrentliabilities": 617004,
    "tradeandothercurrentpayablestorelatedparties": 42433,
    "currentwarrantliability": 4310379,
    "liabilities": 4969816,
    "sharepremium": 17131223,
    "warrantreserve": 459341,
    "reserveofexchangedifferencesontranslation": 2182221,
    "accumulatedothercomprehensiveincome": -21250,
    "retainedearnings": -18768063,
    "equity": 983472,
    "equityandliabilities": 5953288,
    "generalandadministrativeexpense": 4759205,
    "researchanddevelopmentexpense": 1544229,
    "operatingexpense": 6303434,
    "changesinfairvalueofderivativewarrantsliability": -2189986,
    "unrealizedlossonshortterminvestment": 107638,
    "foreignexchangeloss": 78136,
    "otherfinanceincomecost": 59174,
    "financeincomecost": -2316586,
    "revenuefromdividends": 16555,
    "otherincome": 16555,
    "profitlossbeforetax": -8603465,
    "incometaxexpensecontinuingoperations": 17372,
    "profitloss": -8620837,
    "comprehensiveincome": -8620837,
    "basicearningslosspershare": -42.58,
    "weightedaverageshares": 202481,
    "dilutedearningslosspershare": -42.58,
    "adjustedweightedaverageshares": 202481,
    "numberofsharesoutstanding": 607337,
    "issuanceofcommonshares": 6026327,
    "issuanceofcommonshare": 38462,
    "commonsharesandwarrantsissuedtomedigus": 296845,
    "commonsharesandwarrantissuedtomedigus": 1494,
    "issuanceofcommonsharesprefundedwarrantsandwarrants": 1455832,
    "issuanceofcommonsharesprefundedwarrantsandwarrant": 150191,
    "netofissuancecosts": 263408,
    "issuanceofcommonsharesfromuponvestingofrestrictedstockunitsnote8ciivviiinshares": 1391,
    "issuanceofcommonsharesprefundedwarrantsandwarrants1": 1069478,
    "issuanceofcommonsharesprefundedwarrantsandwarrant1": 250000,
    "increasedecreasethroughexerciseofwarrantsequity": 1164117,
    "exerciseofwarrant": 119433,
    "sharesissuedforservices": 148572,
    "sharesissuedforservice": 2374,
    "adjustmentsforsharebasedpayments": 313214,
    "adjustmentsforamortisationexpense": 10954,
    "amortisationexpense": 35381,
    "adjustmentsforinterestexpense": 2907,
    "adjustmentsforunrealisedforeignexchangelossesgains": 78171,
    "issuancecostsallocatedtoderivatewarrantsliability": 468408,
    "adjustmentsfordepreciationexpense": 11175,
    "adjustmentsfordecreaseincreaseinderivativefinancialassets": 2189986,
    "sharebasedcompensations": 366405,
    "adjustmentsforlossesgainsonshortterminvestment": 107638,
    "adjustmentsfordeferredtaxexpense": 17372,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -154621,
    "adjustmentsfordecreaseincreaseinprepaidexpenses": -26134,
    "adjustmentsforincreasedecreaseintradeaccountpayable": -620421,
    "adjustmentsforincreasedecreaseinduetorelatedparties": 167856,
    "cashflowsfromusedinoperatingactivities": -6301472,
    "cashflowsfromusedindecreaseincreaseinrestrictedcashandcashequivalents": -26228,
    "cashflowsfromusedininvestingactivities": -26228,
    "proceedsfromissueofordinaryshares": 11115241,
    "proceedsfromexerciseofwarrants": 590077,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 40922,
    "cashflowsfromusedinfinancingactivities": 11664396,
    "effectofexchangeratechangesoncashandcashequivalents": -37734,
    "increasedecreaseincashandcashequivalents": 5298962,
    "interestreceivedclassifiedasoperatingactivities": 71733,
    "dividendreceived": 16555,
    "incometaxespaidclassifiedasoperatingactivities": 12678,
    "commonsharesissued": 296569,
    "descriptionofaccountingpolicyforbasisofpresentationexplanatory": "a.Basis of Presentation",
    "descriptionofaccountingpolicyforaccountingjudgementsandestimatesexplanatory": "b.Significant Accounting Estimates and Judgments",
    "descriptionofaccountingpolicyforaccountingstandardsissuedbutnotyeteffectiveexplanatory": "r. Accounting Standards Issued But Not Yet Effective",
    "disclosureofpropertyplantandequipmentusefullifetabletextblock": "Depreciation of property and equipment is provided usingthe straight-line method at the following rates approximating their estimated useful lives:",
    "scheduleofrouofficespacetabletextblock": "ROU office space                     Balance, October 31, 2022     $35,730                      Addition      -       Accumulated depreciation      (35,381)      Foreign currency fluctuation      (349)                     Balance, October 31, 2023     $-",
    "amountsrecognizedinprofitorlosstabletextblock": "Year ended             October 31,             2023       Depreciation     $35,381       Interest      2,907       Foreign currency fluctuation      722                            $39,010",
    "scheduleoffairvalueofcommonsharestabletextblock": "As of October 31, 2023, the Company holds 27,778 ordinary sharesof Medigus (approximately 0.11%) with a total fair value of $86,112. The fair value of ordinary shares held was determined by referenceto public price quotations in an active market. See Note 12.",
    "disclosureofinformationaboutderivativewarrantliabilityexplanatory": "The binomial model was used to measure the derivative warrant liability with the following assumptions:",
    "scheduleofthefairvaluehasbeenestimatedusingtheblackscholestabletextblock": "The fair value of the underwriters warrants was estimated using the Black-Scholes option pricing model assuming no expecteddividends or forfeitures and the following weighted average assumptions:",
    "scheduleofsharepurchasewarrantstabletextblock": "The following table summarizes the changes inthe Company’s share purchase warrants:",
    "scheduleofchangesinstockoptionsexplanatory": "The following table summarizes the changes in the Company’s stock options for the years ended October 31, 2023 and October 31, 2022:",
    "scheduleofadditionalinformationregardingstockoptionsoutstandingexplanatory": "Additional information regarding stock options outstanding as of October 31, 2023, is as follows:",
    "scheduleoffairvalueofstockoptionsexplanatory": "The fair value of stock options previouslygranted to certain consultants for ongoing services measured during the period have been estimated using the Black-Scholes option pricingmodel assuming no expected dividends or forfeitures and the following weighted average assumptions:",
    "scheduleofchangesinrsustabletextblock": "The following table summarizes the changes in RSUs:",
    "scheduleofcontractualmaturitiesoffinancialliabilitiesexplanatory": "The following amounts are the contractual maturities offinancial liabilities as of October 31, 2023 and 2022:",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P3Y",
    "depreciationexpense": 35381,
    "foreigncurrencyfluctuation": -349,
    "interestexpenseonleaseliabilities": 40922,
    "interestexpenseonbonds": 2907,
    "foreigncurrencytranslationinleaseliability": -375,
    "depreciationrightofuseassets": 35381,
    "interestinprofitorloss": 2907,
    "foreigncurrencyfluctuationamountsrecognizedprofitandloss": 722,
    "totalamountsrecognizedinprofitorloss": 39010,
    "numberofsharesissued": 86112,
    "unrealizedlosss": -107638,
    "officersmanagementpersonnel": 410066,
    "directorsemploymentservices": 182261,
    "amountsowedtoofficers": 29666,
    "amountsowedtodirectors": 12767,
    "amountsowed": 42433,
    "weightedaveragesharepriceshareoptionsgranted2019": 3.66,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 5.12,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P4Y5M4D",
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0337,
    "descriptionofexpectedvolatilityshareoptionsgrantedrate": 0.7479,
    "issuanceofwarrants": 1771208,
    "proceedsfromexerciseofoptions": 574040,
    "increasedecreaseinfairvaluemeasuremententitysownequityinstruments": 2189986,
    "expectedlifeinyears": "P5Y",
    "descriptionofexpectedvolatilityshareoptionsgranted": 1.5,
    "numberofwarrant": 384369,
    "weightedaverageexerciseprice": 7.9,
    "numberofwarrantsnumberofsharestobeissuedfromtheexerciseofwarrants": 826781,
    "numberofwarrantsissuanceofunderwriterwarrants": 1923,
    "weightedaverageexercisepriceissuanceofunderwriterwarrants": 243.75,
    "numberofwarrantsissuanceofwarrants": 150191,
    "weightedaverageexercisepriceissuanceofwarrantsnote": 5.124,
    "numberofwarrantsissuanceofwarrant": 250000,
    "weightedaverageexercisepriceissuanceofwarrantsnote7a": 9,
    "numberofwarrantsissuanceofmediguswarrants": 75,
    "weightedaverageexercisepriceissuanceofmediguswarrants": 1297.67,
    "numberofwarrantsexpirationofwarrants": -11430,
    "weightedaverageexercisepriceexpirationofwarrants": 922.98,
    "numberofwarrantsexerciseofwarrants": -26153,
    "weightedaverageexercisepriceexerciseofwarrant": 5.124,
    "numberofwarrantsoutstanding": 8333,
    "numberofsharestobeissuedfromtheexerciseofwarrants": 8333,
    "exercisepriceofoutstandingshareoptions2019": 135,
    "expirydate": "2024-04-22",
    "numberofoutstandingsharesoptions": 5588,
    "weightedaverageexercisespriceissued": 603.12,
    "numberofoptionsgranted": 334,
    "weightedaverageexercisepricegranted": 442.22,
    "numberofoptionsoutstandingexercisable": 4039,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 606,
    "numberofstockoptionoutstanding": 533,
    "weightedaverageremainingcontractuallifeyears": "P2Y6M25D",
    "weightedaverageexercisepriceoutstanding": 166.5,
    "numberofstockoptionsexercisable": 400,
    "weightedaverageexercisepriceperexercisable": 166.5,
    "descriptionofexpectedlife": "P5Y7M9D",
    "stockissuedduringperiodsharesrestrictedsharesunitsgranted": 2200,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 55.97,
    "stockissuedduringperiodsharesrestrictedsharesunitsvested": -2200,
    "weightedaverageexercisepriceofshareoptionsvestedinsharebasedpaymentarrangement": 55.97,
    "derivativefinancialliabilities": 4310379,
    "othercashandcashequivalents": 78503,
    "otherreceivables": 104320,
    "adjustmentsforincreasedecreaseinotherliabilities": -177226,
    "tradeandotherpayablestorelatedparties": 42433,
    "increasedecreasethroughforeignexchangeandothermovementsfinancialassets": 36836,
    "netforeignexchangeloss": 3684,
    "impactofastrengtheningorweakeningofforeignexchangerate": 0.1,
    "tradeandothercurrentpayables": 617004,
    "amountspayablerelatedpartytransactions": 42433,
    "financialliabilities": 659437,
    "taxrateeffectfromchangeintaxrate": 0.27,
    "taxexpenseincomeatapplicabletaxrate": -2322936,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 204134,
    "taxeffectofforeigntaxrates": 10715,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 2125459,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 4085,
    "professionalfeesexpense": 2210795,
    "investorrelations": 1565970,
    "expensefromsharebasedpaymenttransactionswithemployees": 221625,
    "consultingfeesexpenses": 96421,
    "insuranceexpense": 364059,
    "transferagentandregulatoryfees": 171439,
    "employeebenefitsexpense": 37838,
    "miscellaneousotheroperatingexpense": 31670,
    "depreciationpropertyplantandequipment": 1915,
    "sellinggeneralandadministrativeexpense": 4759205,
    "researchandpreclinicalstudies": 1159147,
    "salariesregulatoryprofessionalandotherexpenses": 469667,
    "sharebasedcompensationnotes": 45870,
    "reimbursements": -141409,
    "amortisationintangibleassetsotherthangoodwill": 10954,
    "netproceeds": 2936079,
    "othercashpaymentsfromoperatingactivities": 6301472,
    "descriptionofreasonwhypresentationcurrencyisdifferentfromfunctionalcurrency": "The change in the functional currency was accountedfor prospectively from the date of the change by translating all items of the financial statement into the new functional currency usingthe exchange rate of $0.7327 CAD/USD at the date of the change.",
    "proportionofownershipinterestinsubsidiary": 1,
    "liquidinstrumentmaturity": "P3M",
    "postemploymentbenefitexpensedefinedcontributionplans": 13988,
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": 833810,
    "descriptionofextendlease": "The Company,Scisparc and the third party had an option to extend the 2021 Lease for an additional three-year period. The Company’s base rentwas ILS11,000 per month ($3,080) during the term of the 2021 Lease.",
    "borrowingsinterestrate": 0.2,
    "rentalexpense": 18200,
    "shorttermdeposit": 33000,
    "numberofsharesissuedandfullypaid": 27778,
    "percentageofshareholding": 0.0011,
    "totalfairvalue": 86112,
    "proportionofvotingrightsheldinjointventure": 0.5,
    "reimbursementforresearchanddevelopmentexpenses": 131409,
    "issuanceofcommonpricepershare": 195,
    "additionalcommonshares": 5769,
    "commonsharepercentage": 0.15,
    "underwriterwarrants": 1923,
    "weightedaverageshareprice2019": 243.75,
    "fairvalueofunderwriterwarrants": 337579,
    "sharesissued1": 1325,
    "warrantsconvertedintoshares": 685883,
    "restrictedstockunitissued": 2200,
    "fairvalueofassociatedfinancialliabilities": 91589,
    "paymentsforshareissuecosts": 171819,
    "foreigncurrencypercentage": 0.1,
    "applicabletaxrate": 0.23,
    "noncapitallossescarriedforward": 13176000,
    "entityregistrantname": "Clearmind Medicine Inc.",
    "tradingsymbol": "CMND",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--10-31",
    "entitycommonstocksharesoutstanding": 607337,
    "amendmentflag": "false",
    "entitycentralindexkey": 1892500,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-10-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-41557",
    "entityincorporationstatecountrycode": "A1",
    "entityaddressaddressline1": "101 – 1220 West 6th Avenue",
    "entityaddresscityortown": "Vancouver",
    "entityaddresscountry": "CA",
    "contactpersonnelname": "Dr. Adi Zuloff-Shani",
    "entityaddresspostalzipcode": "V6H1A5",
    "cityareacode": 973,
    "localphonenumber": 536.1016,
    "contactpersonnelemailaddress": "invest@clearmindmedicine.com",
    "security12btitle": "Common shares, no par",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 1197,
    "auditorname": "Brightman Almagor Zohar & Co.",
    "auditorlocation": "Tel Aviv, Israel"
  },
  {
    "date": "2022-10-31",
    "symbol": "CMND",
    "period": "FY",
    "cashandcashequivalents": 175768,
    "tradeandothercurrentreceivables": 69518,
    "tradeandothercurrentreceivablesduefromrelatedparties": 64134,
    "currentprepaidexpenses": 19443,
    "shortterminvestmentsclassifiedascashequivalents": 264449,
    "currentassets": 593312,
    "propertyplantandequipment": 17610,
    "intangibleassetsotherthangoodwill": 71119,
    "currentrestrictedcashandcashequivalents": 20000,
    "rightofuseassets": 48768,
    "deferredtaxassets": 270487,
    "noncurrentassets": 534662,
    "assets": 1127974,
    "othernoncurrentliabilities": 1906706,
    "tradeandothercurrentpayablestorelatedparties": 281844,
    "currentderivativefinancialliabilities": 396597,
    "currentleaseliabilities": 52399,
    "liabilities": 2637546,
    "sharepremium": 9153900,
    "issuedcapital": 672945,
    "otherreserves": 626641,
    "reserveofexchangedifferencesontranslation": 1915895,
    "accumulatedothercomprehensiveincome": -29004,
    "retainedearnings": 13849949,
    "equity": -13849949,
    "equityandliabilities": 1127974,
    "generalandadministrativeexpense": 4327334,
    "researchanddevelopmentexpense": 4205245,
    "operatingexpense": 8532579,
    "profitlossfromoperatingactivities": -8532579,
    "unrealizedlossonshortterminvestment": 420646,
    "foreignexchangeloss": 552,
    "interestexpense": 19678,
    "reclassificationadjustmentsonchangeinvalueofforwardelementsofforwardcontractsnetoftax": 396597,
    "financecosts": 837473,
    "profitlossbeforetax": -9370052,
    "incometaxexpensecontinuingoperations": 40754,
    "profitloss": -9410806,
    "foreignexchangedifferencesontranslationofforeignoperations": 29004,
    "shareofothercomprehensiveincomeofassociatesandjointventuresaccountedforusingequitymethodthatwillnotbereclassifiedtoprofitorlossnetoftax": -9439810,
    "basicearningslosspershare": -7.24,
    "weightedaverageshares": 1300050,
    "dilutedearningslosspershare": -7.24,
    "adjustedweightedaverageshares": 1300050,
    "numberofsharesoutstanding": 1319770,
    "sharesissuableforvestedrsus": 372598,
    "sharesissuableforservices": 133734,
    "sharesissuedforservices": 65413,
    "sharesissuedforservice": 2667,
    "netofissuancecosts": 1480227,
    "unitsissuedtomedigusnetofissuancecost": 66245,
    "adjustmentsforsharebasedpayments": 1076438,
    "reclassificationadjustmentsonexchangedifferencesontranslationnetoftax": -29004,
    "comprehensiveincome": -9439810,
    "adjustmentsforamortisationexpense": 20242,
    "amortisationexpense": 82802,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": -19699,
    "depreciationsofpropertyandequipment": -10335,
    "adjustmentsfordecreaseincreaseinderivativefinancialassets": 396597,
    "sharebasedcompensation": 1648183,
    "adjustmentsforlossesgainsonshortterminvestment": 420645,
    "adjustmentsfordeferredtaxexpense": 40754,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": 27214,
    "adjustmentsfordecreaseincreaseinprepaidexpenses": 140620,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 1246570,
    "increaseinduetorelatedparties": -273584,
    "cashflowsfromusedinoperatingactivities": -5083561,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 7593,
    "cashflowsfromusedininvestingactivities": -7593,
    "proceedsfromexerciseofwarrants": 795133,
    "interestpaidclassifiedasfinancingactivities": 19699,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 77031,
    "cashflowsfromusedinfinancingactivities": 698403,
    "effectofexchangeratechangesoncashandcashequivalents": -30918,
    "increasedecreaseincashandcashequivalents": -4423669,
    "sharesobtainedfrommedigusinunitissuancenote8c": 621695,
    "adjustmentsforincreasedecreaseinothercurrentliabilities": 270487,
    "rightofuseassetsobtainedinexchangeforleaseliabilities": 126077,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "1.Nature of Operations and Going Concern ",
    "shortterminvestmenttextblock": "6.Short-termInvestment ",
    "disclosureofsharecapitaltextblock": "8.ShareCapital ",
    "sharepurchasewarrantstextblock": "9.SharePurchase Warrants  ",
    "stockoptionstextblock": "10.StockOptions ",
    "disclosureofcapitalmanagementtextblock": "13.CapitalManagement ",
    "basisofpresentationpolicytextblock": "a.Basisof Presentation ",
    "deferredofferingcostspolicytextblock": "    q. The Company capitalizes certain legal and other third-party fees that are directly related to the Company’s in- process equity financing until such financing is consummated After consummation of such equity financing, these costs are recorded as a reduction of the respective gross proceeds. Should a planned equity financing be abandoned, terminated or significantly delayed, the deferred offering costs are written off to operating expenses.   ",
    "scheduleofrouofficespacetabletextblock": "            ROU    office space                     Balance, October 31, 2021     $–                      Addition      126,077       Accumulated    depreciation      (82,802)      Foreign    currency fluctuation      5,493                      Balance, October 31, 2022     $48,768  ",
    "amountsrecognizedinprofitorlosstabletextblock": "            Year    ended             October    31,             2022       Depreciation          $82,802       Interest        19,699       Foreign    currency fluctuation        (90)                           $102,411   ",
    "scheduleofestimatedusingtheblackscholesoptionpricingmodelassumingnoexpecteddividendstabletextblock": "                2022              2021                                                Risk-free interest rate              2.05    %              0.89    %      Expected life (in years)              8.67                   5           Expected volatility              94.09    %              98    %   ",
    "scheduleofcontractualmaturitiesoffinancialliabilitiestabletextblock": "      2022     Total      Within     1 year       Within     2-5 years                                      Accounts payable    and accrued liabilities     $1,906,706      $1,906,706      $        –       Due to related parties      281,844       281,844       –       Derivative liability        396,597       396,597               Lease    liability      52,399       52,399       –             $2,637,546      $2,637,546      $–    ",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": 3,
    "amortizedcostofcash": "Amortized cost",
    "amountsreceivable": "Amortized cost",
    "accountspayableandaccruedliabilities": "Amortized cost",
    "duetorelatedparties": "Amortized cost",
    "shortterminvestments": "FVTPLFVTPL",
    "beginningbalancecost": 177797,
    "additioncostamount": 20242,
    "propertyplantandequipmentcarryingamountatcostofrevaluedassets": 30798,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 126077,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 55,
    "accumulateddepreciations": 13188,
    "additionsotherthanthroughbusinesscombinationpropertyplantandequipment": 10335,
    "foreigncurrencytranslationaccumulateddepreciations": 281,
    "carryingamounts": 17610,
    "investmentproperty": 48768,
    "depreciationexpense": 82802,
    "foreigncurrencyfluctuation": 5493,
    "leaseliabilities": 52399,
    "additionstorightofuseassets": 124027000000,
    "interestexpenseonleaseliabilities": 96730000000,
    "interestexpenseonbonds": 19699000000,
    "foreigncurrencytranslationinleaseliability": 5403000000,
    "depreciationrightofuseassets": 82802,
    "interestinprofitorloss": 19699,
    "foreigncurrencyfluctuationamountsrecognizedprofitandloss": -90,
    "totalamountsrecognizedinprofitorloss": 102411,
    "numberofsharesissued": 264449,
    "additions": 685095,
    "unrealizedloss": -420646,
    "officersmanagementpersonnel": 1662430,
    "directorsemploymentservices": 229619,
    "amountsowedtoofficers": 185830,
    "amountsowedtodirectors": 96014,
    "amountsowed": 281844,
    "numberofwarrant": 592911,
    "weightedaverageexerciseprice": 26.1,
    "numberofwarrantsissued": 66245,
    "weightedaverageexercisepriceissues": 60,
    "numberofwarrantsoutstanding": 592911,
    "exercisepriceofoutstandingshareoptions2019": 60,
    "expirydate": "August 14, 2023",
    "numberofoutstandingsharesoptions": 157666,
    "weightedaverageexercisespriceissued": 20.45,
    "numberofoptionsgranted": 86333,
    "weightedaveragesharepriceshareoptionsgranted2019": 20.68,
    "numberofoptionscancelled": -40556,
    "weightedaverageexercisepricecancelled": 21.56,
    "numberofoptionsoutstandingexercisableindollars": 71194,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 20.3,
    "exercisepriceshareoptionsgranted2019": 30,
    "numberofstockoptions": 157666,
    "weightedaverageremainingcontractuallifeyears": 6.45,
    "weightedaverageexercisepriceoutstanding": 20.45,
    "numberofstockoptionsexercisable": 71194,
    "weightedaverageexercisepriceexercisable": 20.3,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.020499999999999997,
    "expectedlife": 8.67,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.9409000000000001,
    "stockissuedduringperiodsharesrestrictedsharesunits": 9333,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 8.3,
    "stockissuedduringperiodsharesrestrictedsharesunitsgranted": 51339,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 10.57,
    "stockissuedduringperiodsharesrestrictedsharesunitsvested": -42006,
    "weightedaverageexercisepriceofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement2019": 11.07,
    "noncurrentderivativefinancialliabilities": 396597,
    "othercashandcashequivalents": 169715,
    "otherreceivables": 47846,
    "adjustmentsforincreasedecreaseinotherliabilities": -475464,
    "tradeandotherpayablestorelatedparties": 198146,
    "increasedecreasethroughforeignexchangeandothermovementsfinancialassets": 456049,
    "netforeignexchangeloss": 45605,
    "tradeandothercurrentpayables": 1906706,
    "duetorelatedparties1": 281844,
    "financialliabilities": 2637546,
    "propertyplantandequipmentrecognisedasofacquisitiondate": 17610,
    "restrictedcashandcashequivalents": 20000,
    "otherfinancialassets": 48768,
    "differedofferingcosts": 270768,
    "totalnoncurrentassets": 534662,
    "taxrateeffectfromchangeintaxrate": 0.27,
    "taxeffectfromchangeintaxrate": -2540729,
    "deferredtaxliabilityasset": 457916,
    "taxeffectofforeigntaxrates": 76673,
    "netdeferredtaxassets": 2046894,
    "capitalleasesfutureminimumpaymentsdueinoneyear": 6671,
    "capitalleasesfutureminimumpaymentsdueintwoyear": 104767,
    "capitalleasesfutureminimumpaymentinthreeyear": 102087,
    "capitalleasesfutureminimumpaymentsinfouryear": 243880,
    "capitalleasesfutureminimumpaymentsinfiveyear": 1642704,
    "capitalleasesfutureminimumpaymentsinsixyear": 6684510,
    "financeliabilitypaymentsdue": 8784619,
    "depreciationofrouasset": 82801,
    "consultingfees": 262674,
    "depreciationofpropertyandequipment": 10335,
    "financialassets": 204103,
    "investmentaccountedforusingequitymethod": 645742,
    "officeequipment": 92835,
    "professionalfeesexpense": 1493024,
    "employeebenefitsexpense": 125975,
    "keymanagementpersonnelcompensationsharebasedpayment": 1291638,
    "otherfinancialliabilities": 118207,
    "totalgeneralandadministrative": 4327334,
    "researchandpreclinicalstudies": 2984677,
    "salariesregulatoryprofessionalandotherexpenses": 909194,
    "amortisationintangibleassetsotherthangoodwill": 20242,
    "sharebasedcompensationnotes": 291132,
    "othercashpaymentsfromoperatingactivities": 5083561,
    "increasedecreaseinworkingcapital": 2044234,
    "ownedsubsidiarypercentage": 1,
    "maturityperiod.": "three months",
    "postemploymentbenefitexpensedefinedcontributionplans": 42526,
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": 792571,
    "descriptionofextendlease": "The Company, Scisparc and the third party have an option to extend the 2021 Lease for an additional three-yearperiod. The Company’s base rent was ILS11,000 per month ($4,464) during the term of the 2021 Lease.",
    "borrowingsinterestrate": 0.5,
    "rentalexpense": 18200,
    "numberofsharesissuedandfullypaid": 44829,
    "sharesrate": 7.7,
    "totalfairvalue": 264449,
    "reimbursementforresearch": 194205,
    "owedtothecompanyamount": 64134,
    "sharesissued1": 26498,
    "fairvalueofacquiredreceivables": 621695,
    "priceperunits": 24,
    "proceedsfromissue": 953925,
    "fairvalue": 763140,
    "fairvalueofwarrant": 190785,
    "incurredfindersfee": 63399,
    "fairvalueofcommonshares": 508760,
    "fairvaluewarrant": 112935,
    "percentageofvotingequityinterestsacquired": 0.1,
    "commonshares": 173077,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrants": 86333,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragepricepershare": 20.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvested": 10,
    "proceedsfromexerciseofoptions": 1101438,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 12.75,
    "paymentsforshareissuecosts": 518945,
    "foreigncurrencypercentage": 0.1,
    "sharebasedcompensations": 65413,
    "numberofsharesissued1": 2667,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 9994,
    "numberofresearchprograms": 2,
    "feeandcommissionexpense": 493167,
    "statutoryincometaxpercentage": 0.27,
    "statutorycorporatetaxpercentage": 0.23,
    "noncapitallossescarriedforward": 8785000,
    "noncapitallossescarriedforwardapproximately": 2253000,
    "sharepricepershare": 8.65,
    "sharepercentage": 0.15,
    "underwriterwarrant": 57692,
    "warrantsreceived": 2241,
    "entityregistrantname": "Clearmind Medicine Inc.",
    "tradingsymbol": "CMND",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--10-31",
    "entitycommonstocksharesoutstanding": 1319770,
    "amendmentflag": "false",
    "entitycentralindexkey": 1892500,
    "entitycurrentreportingstatus": "No",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2022-10-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-41557",
    "entityincorporationstatecountrycode": "British Columbia",
    "entityaddressaddressline1": "101 – 1220 West 6th Avenue",
    "entityaddresscityortown": "Vancouver",
    "entityaddresscountry": "CA",
    "contactpersonnelname": "Dr. Adi Zuloff-Shani",
    "entityaddresspostalzipcode": "V6H1A5",
    "cityareacode": 973,
    "localphonenumber": 536.1016,
    "security12btitle": "Common shares, no par",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 1197,
    "auditorname": "SATURNA GROUP CHARTERED PROFESSIONAL ACCOUNTANTS LLP",
    "auditorlocation": "Vancouver, Canada",
    "documentannualreport": "true",
    "documentregistrationstatement": "false",
    "documentshellcompanyreport": "false",
    "documenttransitionreport": "false"
  }
]